ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes

ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes

Bibliographic Details
Main Authors:	Horton, V, Groves, C, Naylor, M, Owen, R, Wiltshire, S, Stratton, I, Green, F, Holman, R
Format:	Journal article
Published:	2000

Similar Items

Butyrylcholinesterase K variant is associated with type 2 diabetes in UK Caucasians
by: Hashim, Y, et al.
Published: (2000)

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.
by: Hashim, Y, et al.
Published: (2001)

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.
by: Kehoe, P, et al.
Published: (1998)

Butyrylcholinesterase K variant on chromosome 3q is associated with Type II diabetes in white Caucasian subjects (vol 44, pg 2227, 2001)
by: Hashim, Y, et al.
Published: (2002)

Erratum: Butyrylcholinesterase K variant on chromosome 3q is associated with Type II diabetes in white Caucasian subjects (Diabetologia (2001) 44 (2227-2230))
by: Hashim, Y, et al.
Published: (2002)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
by: Holman, R, et al.
Published: (2001)

Flavonoids as Inhibitors of Human Butyrylcholinesterase Variants
by: Maja Katalinić, et al.
Published: (2014-01-01)

Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients
by: Groves, C, et al.
Published: (1998)

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
by: Tasker, A, et al.
Published: (2008)

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
by: Roger M. Lane, et al.
Published: (2024-04-01)

APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
by: Burwick, R, et al.
Published: (2006)

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.
by: Evangelou, N, et al.
Published: (1999)

APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
by: E Losonczi, et al.
Published: (2010-11-01)

Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon2/epsilon3/epsilon4 genotype.
by: Keavney, B, et al.
Published: (2003)

The electron pressure in the outer atmosphere of epsilon Eri (K2 V)
by: Jordan, C, et al.
Published: (2001)

Modelling the chromosphere and transition region of epsilon Eri (K2 V)
by: Sim, SA, et al.
Published: (2005)

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
by: Lehmann, D, et al.
Published: (2000)

Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.
by: Filippini, N, et al.
Published: (2009)

Risk factors for coronary heart disease in non-insulin dependent diabetic subjects
by: Turner, R, et al.
Published: (1996)

CHARGE ASYMMETRY AND WEAK INTERACTION EFFECTS IN EPSILON+ EPSILON- -] MU+ MU- AND EPSILON+ EPSILON- -] TAU+ TAU-
by: Brandelik, R, et al.
Published: (1982)

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.
by: Enzinger, C, et al.
Published: (2004)

Risk of heart failure in type 2 diabetes
by: Coleman, R, et al.
Published: (2003)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
Published: (2011-01-01)

Computational study of decaying annular vortex flow using the R-epsilon/K-epsilon turbulence model
by: Saqr, Khalid M., et al.
Published: (2012)

A study of velocity fields in the transition region of epsilon Eri (K2 V)
by: Sim, SA, et al.
Published: (2003)

On the filling factor of emitting material in the upper atmosphere of epsilon Eri (K2 V)
by: Sim, SA, et al.
Published: (2003)

Patient with hereditary butyrylcholinesterase deficiency
by: Lina Arianna Hernadez Peraza, et al.
Published: (2023-03-01)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
by: Stevens, R, et al.
Published: (2002)

EVALUATION OF K-EPSILON MODEL FOR TURBULENT BUOYANT JET
by: Osman Abu Bakr Mohmmed Ahmed, et al.
Published: (2019-10-01)

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
by: Lai, M, et al.
Published: (2006)

APOE epsilon 4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
by: Lai, M, et al.
Published: (2006)

Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer’s Disease in the Lithuanian Population
by: Greta Pšemeneckienė, et al.
Published: (2019-10-01)

EMERGENCY ALARMS IN LAHORE AS EPSILON VARIANT OF COVID-19 IS DETECTED
by: Hassan Sohail Butt, et al.
Published: (2022-03-01)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
by: Holmes, C, et al.
Published: (2005)

Fire-and-forget in prevention of coronary heart disease.
by: Karpe, F, et al.
Published: (2002)

APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2002)

Butyrylcholinesterase–Protein Interactions in Human Serum
by: Jacek Jasiecki, et al.
Published: (2021-10-01)

2-Benzoyl-6-benzylidenecyclohexanone analogs as potent dual inhibitors of acetylcholinesterase and butyrylcholinesterase
by: Sze, Wei Leong, et al.
Published: (2016)

2-Hydroxy-<i>N</i>-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase
by: Martin Krátký, et al.
Published: (2019-11-01)

Effects of physical exercise on butyrylcholinesterase in obese adolescents
by: Isabela M.W. Silva, et al.
Published: (2012-01-01)